I’ve had a positive impression of HKRoids based on previous third-party testing, and I’ve ordered several kinds of peptides from HK before. However, on Finnrick I came across this third-party analysis from April 2026 of batch 2AZK2RJ labeled as Tirzepatide, where the lab concluded that the vial actually contained Retatrutide instead. The report was marked as failed due to the identity mismatch.
You can view the report here. You need to be logged in to access it, but creating an account is free. I have also attached the CoA to this post:
Finnrick report
This seems like a serious labeling or production mix-up if the result is accurate. Has anyone from the team looked into this batch specifically, or is there any explanation regarding the result and the testing methodology used?
You can view the report here. You need to be logged in to access it, but creating an account is free. I have also attached the CoA to this post:
Finnrick report
This seems like a serious labeling or production mix-up if the result is accurate. Has anyone from the team looked into this batch specifically, or is there any explanation regarding the result and the testing methodology used?